Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant  or a left ventricular assist device (LVAD).

News | Ventricular Assist Devices (VAD)

February 11, 2019 — Heart failure experts at the National Research Center for Cardiac Surgery in Astana, Kazakhstan ...

Home February 11, 2019
Home
News | Stem Cell Therapies

February 1, 2019 — A team of Rutgers scientists have taken an important step toward the goal of making diseased hearts ...

Home February 01, 2019
Home
News | ECG

January 8, 2019 — A Mayo Clinic study finds that applying artificial intelligence (AI) to a widely available ...

Home January 08, 2019
Home
Videos | Heart Failure

Andreas Brieke, M.D., director of mechanical circulatory support, heart failure physician and site principal ...

Home December 20, 2018
Home
News | Atrial Fibrillation

December 18, 2018 — Irish medical device company AuriGen Medical won the prestigious Global Innovation Award at the ...

Home December 18, 2018
Home
Blog
 


There are numerous factors that impact the larger picture in cardiology, especially from a business perspective ...
Home December 11, 2018
Home
An example of artificial intelligence-aided clinical decision support software for a heart failure patient from the vendor HealthReveal. The AI pulled in relevant patient data from the electronic medical record and offers recommendations for care based on current American Heart Association (AHA) guidelines. It also offers the citations for where to find the guidelines and prescribing information for the recommended drug. Machine learning for cardiology.
Feature | Artificial Intelligence | Lonny Reisman, M.D.

The consistent provision of guideline-directed medical therapy (GDMT) — care delivered according to established ...

Home December 06, 2018
Home
News | Pharmaceuticals

November 15, 2018 — AstraZeneca announced positive full results from the DECLARE-TIMI 58 cardiovascular (CV) outcomes ...

Home November 15, 2018
Home
Russel Pate, Ph.D., Univerity Of South Carolina, chair of the National Physical Activity Plan Alliance. #AHA18
Feature | AHA

November 7, 2018 — Here is a list of some of the key clinical trial presentations at the 2018 American Heart Association ...

Home November 20, 2018
Home
News | Heart Failure

November 6, 2018 – Initial results from the real-world EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) ...

Home November 07, 2018
Home
News | Heart Failure

November 2, 2018 — In a new study, acute heart failure patients who received individualized treatment by blood volume ...

Home November 02, 2018
Home
News | Heart Failure

November 1, 2018 — Daxor Corp. has entered an agreement with CHF Solutions to explore clinical synergies between Daxor’s ...

Home November 01, 2018
Home
News | Heart Failure

October 29, 2018 — The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, is ...

Home October 29, 2018
Home
A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.
Feature | Heart Failure

October 19, 2018 — Abbott announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U.S ...

Home October 19, 2018
Home
Subscribe Now